Clinical trials
Phase 3 Pancreatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
175 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 10 |
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 11 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 11 |
| 2015 | 10 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 12 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 81 |
| Recruiting | 29 |
| Unknown status | 26 |
| Terminated | 22 |
| Not yet recruiting | 7 |
| Active, not recruiting | 6 |
| Withdrawn | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 9 |
| Memorial Sloan Kettering Cancer Center | 5 |
| Revolution Medicines, Inc. | 5 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 4 |
| Sanofi | 4 |
| Astex Pharmaceuticals, Inc. | 3 |
| Cancer Advances Inc. | 3 |
| Incyte Corporation | 3 |
| M.D. Anderson Cancer Center | 3 |
| SWOG Cancer Research Network | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 175 |
| Neoplasms | 10 |
| Neoplasm Metastasis | 9 |
| Adenocarcinoma | 6 |
| Bile Duct Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colonic Neoplasms | 5 |
| Esophageal Neoplasms | 4 |
| Liver Neoplasms | 4 |
Trials
Showing 26 to 50 of 175. Each trial links to its page on Pharma Observatory.
75 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.